Key result
Aging is associated with a stable platelet count that falls in old age and an increase in platelet function during middle age, driven by changes in hematopoietic tissue and oxidative stress.
This review highlights the critical gap in understanding platelet function in the elderly (>75 years), emphasizing that age-related changes in platelet biology must be addressed to develop more precise anti-platelet therapies for older patients.
Answers are grounded in this paper and cite their sources.
Challenges longstanding view of rising platelet reactivity with age; leaves open whether age should inform antiplatelet strategies in trials.
There are clear age-related changes in platelet count and function, driven by changes in hematopoietic tissue, the composition of the blood and vascular health. Platelet count remains relatively stable during middle age (25-60 years old) but falls in older people. The effect of age on platelet function is slightly less clear. The longstanding view is that platelet reactivity increases with age in an almost linear fashion. There are, however, serious limitations to the data supporting this dogma. We can conclude that platelet function increases during middle age, but little evidence exists on the changes in platelet responsiveness in old age (>75 years old). This change in platelet function is driven by differential mRNA and microRNA expression, an increase in oxidative stress and changes in platelet receptors. These age-related changes in platelets are particularly pertinent given that thrombotic disease and use of anti-platelet drugs is much more prevalent in the elderly population, yet the majority of platelet research is carried out in young to middle-aged (20-50 years old) human volunteers and young mice (2-6 months old). We know relatively little about exactly how platelets from people over 75 years old differ from those of middle-aged subjects, and we know even less about the mechanisms that drive these changes. Addressing these gaps in our knowledge will provide substantial understanding in how cell signalling changes during ageing and will enable the development of more precise anti-platelet therapies.
No takes yet. Share an insight, caveat, or question.
Chris I. Jones (2016) conducted a review in Aging and platelet function. Aging vs. Younger age was evaluated. Aging is associated with a stable platelet count that falls in old age and an increase in platelet function during middle age, driven by changes in hematopoietic tissue and oxidative stress.
Synapse has enriched 10 related papers. Consider them for comparative context: